Please enable JavaScript to continue using this application.

Compare $BIOQ vs $NXTC | Chartloom

Compare

$BIOQ vs $NXTC

Bioqual Inc · NextCure Inc

BIOQ

Bioqual Inc

NXTC

NextCure Inc

Compare $BIOQ vs $NXTC

Comparing Bioqual Inc and NextCure Inc

BIOQBioqual Inc

NXTCNextCure Inc

BIOQBioqual Inc

Market cap

$29M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.4%

YTD performance

-14.3%

52W performance

-40.0%

FCF yield

20.2%

NXTCNextCure Inc

Market cap

$29M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-45.9%

52W performance

4.8%

FCF yield

-126.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIOQ

NXTC

Detailed metrics comparison

BIOQ

Bioqual Inc

NXTC

NextCure Inc

Market Cap

BIOQ$29M

NXTC$29M

Enterprise Value

BIOQ$18M

NXTC$14M

Price

BIOQ$33.00

NXTC$7.18

P/E Ratio

BIOQN/A

NXTCN/A

P/S Ratio

BIOQ0.69x

NXTC0.85x

EV/Sales

BIOQ0.43x

NXTC0.29x

EV/EBITDA

BIOQ7.55x

NXTC0.00x

P/B Ratio

BIOQ0.84x

NXTC1.92x

P/FCF Ratio

BIOQ4.95x

NXTCN/A

EV/FCF

BIOQ3.05x

NXTC-0.38x

PEG Ratio

BIOQN/A

NXTCN/A

Forward P/E (NTM)

BIOQN/A

NXTCN/A

Forward P/S (NTM)

BIOQN/A

NXTCN/A

Revenue (TTM)

BIOQ$42M

NXTC$0

Revenue Growth (YoY)

BIOQ-19.4%

NXTCN/A

Forward Rev Growth

BIOQ0.0%

NXTC0.0%

Gross Margin (TTM)

BIOQ7.9%

NXTC0.0%

Operating Margin (TTM)

BIOQ0.0%

NXTC0.0%

EBITDA Margin (TTM)

BIOQ-0.1%

NXTC0.0%

Net Margin (TTM)

BIOQ-2.9%

NXTC0.0%

FCF Margin (TTM)

BIOQ14.0%

NXTCN/A

Net Income (TTM)

BIOQ$-1M

NXTC$-43M

FCF (TTM)

BIOQ$6M

NXTC$-37M

EPS (TTM)

BIOQ-$1.38

NXTC-$8.05

ROE (TTM)

BIOQ-346.0%

NXTC-17546.0%

ROA (TTM)

BIOQ-193.0%

NXTC-11370.0%

ROIC (TTM)

BIOQ-346.0%

NXTC-17546.0%

Cash

BIOQ$11M

NXTC$15M

Debt

BIOQ$0

NXTC$0

Net Cash/Debt

BIOQ$11M

NXTC$15M

Current Ratio (TTM)

BIOQ4.01x

NXTC3.47x

Quick Ratio (TTM)

BIOQ3.91x

NXTC3.13x

Debt/Equity (TTM)

BIOQ0.00x

NXTC0.00x

Debt/Assets (TTM)

BIOQ0.0%

NXTC0.0%

Interest Coverage (TTM)

BIOQN/A

NXTCN/A

Net Debt/EBITDA (TTM)

BIOQ0.00x

NXTC0.00x

Beta

BIOQ-0.48

NXTC1.29

52W Performance

BIOQ-40.0%

NXTC4.8%

YTD Performance

BIOQ-14.3%

NXTC-45.9%

% from 52W High

BIOQ-69.6%

NXTC-54.4%

% from 52W Low

BIOQ1.5%

NXTC363.2%

Asset Turnover (TTM)

BIOQ0.66x

NXTC0.10x

FCF Yield (TTM)

BIOQ20.2%

NXTC-126.6%

Earnings Yield (TTM)

BIOQ-4.2%

NXTC-146.3%

Dividend Yield (TTM)

BIOQN/A

NXTCN/A

Rule of 40

BIOQ-5.4

NXTC0.0

EV/GP/RG

BIOQN/A

NXTCN/A

Ticker research

View BIOQ research View NXTC research

Metric	BIOQ Bioqual Inc	NXTC NextCure Inc
Market & Valuation
Market Cap	$29M	$29M
Enterprise Value	$18M	$14M
Price	$33.00	$7.18
P/E Ratio	N/A	N/A
P/S Ratio	0.69x	0.85x
EV/Sales	0.43x	0.29x
EV/EBITDA	7.55x	0.00x
P/B Ratio	0.84x	1.92x
P/FCF Ratio	4.95x	N/A
EV/FCF	3.05x	-0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$42M	$0
Revenue Growth (YoY)	-19.4%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	7.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.1%	0.0%
Net Margin (TTM)	-2.9%	0.0%
FCF Margin (TTM)	14.0%	N/A
Net Income (TTM)	$-1M	$-43M
FCF (TTM)	$6M	$-37M
EPS (TTM)	-$1.38	-$8.05
ROE (TTM)	-346.0%	-17546.0%
ROA (TTM)	-193.0%	-11370.0%
ROIC (TTM)	-346.0%	-17546.0%
Financial Health
Cash	$11M	$15M
Debt	$0	$0
Net Cash/Debt	$11M	$15M
Current Ratio (TTM)	4.01x	3.47x
Quick Ratio (TTM)	3.91x	3.13x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.48	1.29
52W Performance	-40.0%	4.8%
YTD Performance	-14.3%	-45.9%
% from 52W High	-69.6%	-54.4%
% from 52W Low	1.5%	363.2%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.10x
FCF Yield (TTM)	20.2%	-126.6%
Earnings Yield (TTM)	-4.2%	-146.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIOQ research	View NXTC research

Valuation

P/S Ratio

BIOQ

0.69x

NXTC

0.85x

EV/FCF

NXTC

-0.38x

BIOQ

3.05x

Growth & revenue

Revenue Growth TTM

BIOQ

-19.4%

Forward Revenue Growth

BIOQ

0.0%

NXTC

0.0%

Profitability & performance

Gross Margin

BIOQ

7.9%

NXTC

0.0%

ROE

BIOQ

-346.0%

NXTC

-17546.0%

FCF Yield %

BIOQ

20.2%

NXTC

-126.6%

52-Week Performance

NXTC

4.8%

BIOQ

-40.0%

Detailed metrics comparison

BIOQ

Bioqual Inc

NXTC

NextCure Inc

Market Cap

BIOQ$29M

NXTC$29M

Enterprise Value

BIOQ$18M

NXTC$14M

Price

BIOQ$33.00

NXTC$7.18

P/E Ratio

BIOQN/A

NXTCN/A

P/S Ratio

BIOQ0.69x

NXTC0.85x

EV/Sales

BIOQ0.43x

NXTC0.29x

EV/EBITDA

BIOQ7.55x

NXTC0.00x

P/B Ratio

BIOQ0.84x

NXTC1.92x

P/FCF Ratio

BIOQ4.95x

NXTCN/A

EV/FCF

BIOQ3.05x

NXTC-0.38x

PEG Ratio

BIOQN/A

NXTCN/A

Forward P/E (NTM)

BIOQN/A

NXTCN/A

Forward P/S (NTM)

BIOQN/A

NXTCN/A

Revenue (TTM)

BIOQ$42M

NXTC$0

Revenue Growth (YoY)

BIOQ-19.4%

NXTCN/A

Forward Rev Growth

BIOQ0.0%

NXTC0.0%

Gross Margin (TTM)

BIOQ7.9%

NXTC0.0%

Operating Margin (TTM)

BIOQ0.0%

NXTC0.0%

EBITDA Margin (TTM)

BIOQ-0.1%

NXTC0.0%

Net Margin (TTM)

BIOQ-2.9%

NXTC0.0%

FCF Margin (TTM)

BIOQ14.0%

NXTCN/A

Net Income (TTM)

BIOQ$-1M

NXTC$-43M

FCF (TTM)

BIOQ$6M

NXTC$-37M

EPS (TTM)

BIOQ-$1.38

NXTC-$8.05

ROE (TTM)

BIOQ-346.0%

NXTC-17546.0%

ROA (TTM)

BIOQ-193.0%

NXTC-11370.0%

ROIC (TTM)

BIOQ-346.0%

NXTC-17546.0%

Cash

BIOQ$11M

NXTC$15M

Debt

BIOQ$0

NXTC$0

Net Cash/Debt

BIOQ$11M

NXTC$15M

Current Ratio (TTM)

BIOQ4.01x

NXTC3.47x

Quick Ratio (TTM)

BIOQ3.91x

NXTC3.13x

Debt/Equity (TTM)

BIOQ0.00x

NXTC0.00x

Debt/Assets (TTM)

BIOQ0.0%

NXTC0.0%

Interest Coverage (TTM)

BIOQN/A

NXTCN/A

Net Debt/EBITDA (TTM)

BIOQ0.00x

NXTC0.00x

Beta

BIOQ-0.48

NXTC1.29

52W Performance

BIOQ-40.0%

NXTC4.8%

YTD Performance

BIOQ-14.3%

NXTC-45.9%

% from 52W High

BIOQ-69.6%

NXTC-54.4%

% from 52W Low

BIOQ1.5%

NXTC363.2%

Asset Turnover (TTM)

BIOQ0.66x

NXTC0.10x

FCF Yield (TTM)

BIOQ20.2%

NXTC-126.6%

Earnings Yield (TTM)

BIOQ-4.2%

NXTC-146.3%

Dividend Yield (TTM)

BIOQN/A

NXTCN/A

Rule of 40

BIOQ-5.4

NXTC0.0

EV/GP/RG

BIOQN/A

NXTCN/A

Ticker research

View BIOQ research View NXTC research

Metric	BIOQ Bioqual Inc	NXTC NextCure Inc
Market & Valuation
Market Cap	$29M	$29M
Enterprise Value	$18M	$14M
Price	$33.00	$7.18
P/E Ratio	N/A	N/A
P/S Ratio	0.69x	0.85x
EV/Sales	0.43x	0.29x
EV/EBITDA	7.55x	0.00x
P/B Ratio	0.84x	1.92x
P/FCF Ratio	4.95x	N/A
EV/FCF	3.05x	-0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$42M	$0
Revenue Growth (YoY)	-19.4%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	7.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.1%	0.0%
Net Margin (TTM)	-2.9%	0.0%
FCF Margin (TTM)	14.0%	N/A
Net Income (TTM)	$-1M	$-43M
FCF (TTM)	$6M	$-37M
EPS (TTM)	-$1.38	-$8.05
ROE (TTM)	-346.0%	-17546.0%
ROA (TTM)	-193.0%	-11370.0%
ROIC (TTM)	-346.0%	-17546.0%
Financial Health
Cash	$11M	$15M
Debt	$0	$0
Net Cash/Debt	$11M	$15M
Current Ratio (TTM)	4.01x	3.47x
Quick Ratio (TTM)	3.91x	3.13x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.48	1.29
52W Performance	-40.0%	4.8%
YTD Performance	-14.3%	-45.9%
% from 52W High	-69.6%	-54.4%
% from 52W Low	1.5%	363.2%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.10x
FCF Yield (TTM)	20.2%	-126.6%
Earnings Yield (TTM)	-4.2%	-146.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIOQ research	View NXTC research